Malady Kyle
EVP and Group CEO-VZ Business
Malady Kyle has filed 7 SEC Form 4 filings (13 transaction rows) across 2 companies, including VZ, DXCM, with disclosures dating back to 2025. 7 of those filings fall inside the rolling window. Most recent filing: Sep 2, 2026.
On the most recent filing, Malady Kyle is listed as EVP and Group CEO-VZ Business at VERIZON COMMUNICATIONS INC. Inside the rolling window, Malady Kyle reported no open-market purchases and 4 open-market sales totaling $218K in VZ and DXCM. The largest disclosed transaction in the window is a sale of 1,100 VZ shares on Sep 1, 2026, worth $56K.
Companies traded
Other insiders at VZ
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$218K
reported sales (SEC code S)
Companies
2
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Malady Kyle made?
Malady Kyle has filed 7 SEC Form 4 filings (13 transaction rows) across 2 companies, including VZ, DXCM since 2025.
Which companies does Malady Kyle trade?
Malady Kyle has filed SEC Form 4 disclosures for 2 companies, including VZ, DXCM.
When was Malady Kyle's most recent SEC Form 4 filing?
Malady Kyle's most recent SEC Form 4 filing on Tracefour is dated Sep 2, 2026.
What is Malady Kyle's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Malady Kyle is listed as EVP and Group CEO-VZ Business.
What is Malady Kyle's total buy and sell value in the current window?
Inside the rolling retention window, Malady Kyle bought $0 and sold $218K based on SEC Form 4 filings.
What was Malady Kyle's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 1,100 VZ shares on 2026-09-01, worth $56K, per SEC Form 4 filings.